v3.25.2
CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Thousands
Jun. 30, 2025
Dec. 31, 2024
Current assets:    
Cash and cash equivalents $ 337,304 $ 303,242
Patient accounts receivable 295,521 296,075
Prepaid expenses 18,282 13,072
Other current assets 11,091 19,694
Total current assets 662,198 632,083
Property and equipment, net of accumulated depreciation of $104,613 and $100,890 38,273 42,108
Operating lease right of use assets 86,614 81,500
Goodwill 1,213,888 1,213,888
Intangible assets, net of accumulated amortization of $21,134 and $18,787 79,243 81,155
Other assets 135,169 87,980
Total assets 2,215,385 2,138,714
Current liabilities:    
Accounts payable 29,789 39,956
Payroll and employee benefits 138,515 151,995
Accrued expenses 150,379 152,564
Termination fee paid by UnitedHealth Group 106,000 106,000
Current portion of long-term obligations 36,799 37,968
Current portion of operating lease liabilities 26,879 25,909
Total current liabilities 488,361 514,392
Long-term obligations, less current portion 326,425 339,313
Operating lease liabilities, less current portion 60,404 56,111
Deferred income tax liabilities 64,445 48,051
Other long-term obligations 847 882
Total liabilities 940,482 958,749
Commitments and Contingencies—Note 7  
Equity:    
Preferred stock, $0.001 par value, 5,000,000 shares authorized; none issued or outstanding 0 0
Common stock, $0.001 par value, 60,000,000 shares authorized; 38,476,503 and 38,307,521 shares issued; 32,881,262 and 32,776,148 shares outstanding 38 38
Additional paid-in capital 833,099 818,201
Treasury stock, at cost, 5,595,241 and 5,531,373 shares of common stock (480,859) (474,854)
Retained earnings 880,252 791,156
Total Amedisys, Inc. stockholders’ equity 1,232,530 1,134,541
Noncontrolling interests 42,373 45,424
Total equity 1,274,903 1,179,965
Total liabilities and equity $ 2,215,385 $ 2,138,714